Jolly Good/Teijin Pharma develop VR digital therapeutics for depression
pharmaphorum
APRIL 26, 2021
Using technologies such as VR and AI, the company aims to accelerate human growth and social rehabilitation in medical education and provide support for people with disabilities, as well as provide treatments for mental illness. The post Jolly Good/Teijin Pharma develop VR digital therapeutics for depression appeared first on.
Let's personalize your content